Your session is about to expire
← Back to Search
Exercise for Healthy Subjects
N/A
Waitlist Available
Led By Dennis T Villareal, MD
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after about 2 hours exercise
Awards & highlights
No Placebo-Only Group
Summary
This trial will study how a moderate-intensity aerobic workout affects gene activity in people with type 2 diabetes and metabolic disorders. The goal is to understand how exercise changes genes in muscle tissue to improve metabolism. Participants will have muscle samples taken to analyze these changes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately after about 2 hours exercise
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after about 2 hours exercise
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in JunD/AP-1 signaling in human skeletal muscle
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Exercise groupExperimental Treatment1 Intervention
Research volunteers will be asked to undergo an acute bout of aerobic exercise at moderate intensity for \~120 minutes. Before and after the exercise the volunteer will undergo leg biopsy.
Find a Location
Who is running the clinical trial?
Baylor College of MedicineLead Sponsor
1,022 Previous Clinical Trials
6,029,404 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,439 Previous Clinical Trials
4,324,808 Total Patients Enrolled
US Department of Veterans AffairsFED
873 Previous Clinical Trials
497,825 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger